Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 11, Special Issue 6 (2022)

Buchanania lanzan Spreng (Chironji): An endangered socio-economic forest tree species of Central India

Author(s):
Manish Kumar Vijay, Radhe Shyam Sharma, Shiv Ratan Maloo, Vikas Jain and Asheesh Sharma
Abstract:
Buchanania lanzan Spreng (Chironji), is a member of the family Anacardiaceae. It exhibits an extensive therapeutic profile which has proven to be a socio-economic boon to the tribal community. Plant parts such as leaves, seeds, bark, and kernels have been shown to retain a variety of metabolites with great potential. Presently, B. lanzan is grouped as non-nationalized minor forest produce and widely distributed in the forest regions. Indiscriminate and improper harvesting, climate change, large-scale urbanization and developmental activities, lead to a very severe threat of its existence. It has been classified as a red-listed medicinal plant species of Indian origin, necessitating a comprehensive conservation strategy, as reported by many organisations. The major problem in the reforestation or domestication of this species is the low percentage of seed germination due to hard seed coats, recalcitrant in nature, and fungal contamination associated with the storage of seeds. Vegetative propagation has also not proved successful in this species so far. Thus to augment its sustainable production and conservation, proper research support is an urgent requirement for addressing the problems and further multiplication in the forest area. Also, need to promote awareness among various stakeholders regarding the conservation of this valuable species.
Pages: 336-342  |  338 Views  207 Downloads
How to cite this article:
Manish Kumar Vijay, Radhe Shyam Sharma, Shiv Ratan Maloo, Vikas Jain and Asheesh Sharma. Buchanania lanzan Spreng (Chironji): An endangered socio-economic forest tree species of Central India. The Pharma Innovation Journal. 2022; 11(6S): 336-342.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal